. 2020 Oct 19;11:575492. doi: 10.3389/fimmu.2020.575492

Table 3.

20 publications found in addition to those of Table 2, using broader PubMed search terms ( Supplementary Figure 1 ). Only those found relevant to the present chronic GvHD review have been listed.

Publication	Gene	Population	Genome	Graft	N	Variation	Allele/genotype^a	Statistic	95% CI	P
Norden et al. (28)	GR	EUR	D	MRD	458 pairs	rs6198, rs33388, rs33389	non-ACT	OR 0.374	0.16–0.85	0.025
Kielsen et al. (29)	IL-7Rα	EUR	D	MRD, MUD, URD	460 donors	rs6897932	T	HR 2.0	1.1–3.6	0.025
Takahashi et al. (30)	NLRP3	Japanese	D	MUD	677 pairs	rs10925027	T x HLA-C MM	SHR 2.02	1.30–3.13	0.002
Inamoto et al. (31)	BANK1	US	D	MRD, MUD, MMRD, MMUD	847 recipients, 808 donors	rs10516487	TT	HR 0.43	0.21–0.87	0.02
	CD247		D			rs2056626	GG or GT	HR 1.23	1.00–1.51	0.04
	CD247		R			rs2056626	GG or GT	HR 1.24	1.01–1.52	0.04
	HLA-DPA1		D			rs987870	CC or CT	HR 2.50	1.22–5.11	0.01
	HLA-DPA1		R			rs987870	CC or CT	HR 2.13	1.00–4.54	0.05
Resende et al. (32)	IL17A	Brazilian	R	MRD, MUD, MMUD	34 pairs	rs2275913	AA	NA	NA	0.03^b
Guillem et al. (33)	TYMP	EUR	D	MRD	448 pairs	rs112723255	GG	HR 1.7	1.00–2.70	0.039
Shamim et al. (34)	IL-7Rα	Caucasian	D	URD	590 pairs	rs14944558	TT	NA	NA	0.002^c
Shamim et al. (34)	IL-7Rα	Caucasian	D	URD	590 pairs	rs1494555	GG	NA	NA	0.004^c
Clark et al. (35)	BAFF	European-American	R	MRD, MUD	156 recipients, 153 donors	rs16972217	A	OR 2.72	1.38–5.39	0.004
			R			rs7993590	T	OR 2.35	1.22–4.55	0.011
			R			rs12428930	C	OR 2.53	1.27–5.04	0.008
			R			rs2893321	G	OR 2.48	1.25–4.92	0.009
Takami et al. (36)	FCGR3A	Japanese	R	MUD	99 pairs	rs396991	T	HR 0.45	0.20–0.99	0.049
Sellami et al. (37)	CTLA4	Tunisian	D	MRD	112 pairs	rs231775	G	OR 2.58	1.05–6.32	0.032^c
Inamoto et al. (38)	CCR9	Japanese	D	MRD	167 donors	rs12721497	AG	HR 4.1	1.1–15	0.036
Kornblit et al. (39)	HMGB1	EUR	D	MRD, MMRD, MUD, MMUD	275 recipients, 274 donors	rs2249825	G	HR 1.53	1.15–2.05	0.004^d
	HMGB1		D			rs3742305	C	HR 1.57	1.18–2.09	0.002^d
	HMGB1		D			rs41376448	insT	HR 1.57	1.17–2.12	0.003^d
Boukouaci et al. (40)	MICA	EUR	R	MRD	211 pairs	rs1051792	GG	HR 1.61	1.08–2.40	0.019
Bertinetto et al. (41)	TNFA	EUR	R	MRD	77 pairs	rs361525	GG	NA	NA	0.027^c
Laguila Visentainer et al. (42)	IL6	Brazilian	R	MRD	118 pairs	rs1800795	CC	RR 3.87	1.01–14.86	0.049
Laguila Visentainer et al. (42)	IL6	Brazilian	D	MRD	118 pairs	rs1800795	CC	RR 6.64	2.26–19.54	<0.001
Bogunia-Kubik et al. (43)	IFNγ	EUR	R	RD, URD	160 recipients	Microsatellite (CA)	3/3 genotype	OR 3.18	1.22–8.27	0.018
Stark et al. (44)	TNFR2	EUR	D	MRD	104 pairs	rs1061622	GG	OR 11	NA	0.024
Cullup et al. (45)	IL1α	EUR	D	MRD	98 patients, 94 donors	rs1800587	T	0R 4.364	NA	0.032^e
	IL1α		D			Intron 6 VNTR	Allele 2	OR 6.832	NA	0.008
	IL6		R			rs1800795	GG	OR 5.603	NA	0.016
Cavet et al. (46)	IL6	EUR	R	MRD	80 pairs	rs1800795	GG	OR 4.25	1.49–12.16	0.007
Takahashi et al. (47)	IL10	Japanese	D^f	MRD + URD	54 recipients	–1,064 microsatellite, CA repeats	Allele ≥13	OR 4.5	1.3–16.1	0.020

CI, confidence interval; D, donor; EUR, European; HR, hazard ratio; MMRD, mismatched related donor; MMUD, mismatched unrelated donor; MRD, matched related donor, MUD, matched unrelated donor; NA, not available; OR, odds ratio; R, recipient, RD, related donor; RR, risk ratio; SHR, subdistribution hazard ratio; URD, unrelated donor; US, United States; VNTR, variable number tandem repeat.

^aThe effective allele or genotype.

^bChi-square test, frequencies only.

^cUnivariate analysis, not significant in multivariate analysis.

^dResults significant only in the myeloablative cohort, non-significant in the nonmyeloablative cohort.

^eNot significant if donor VNTR is also included.

^f“Donor-derived”, DNA samples are from recipients after the transplantation.